
Vitamin B1 solved the mystery of beriberi. A century later, deficiencies are still slipping under the radar. Celeste McGovern investigates the consequences for the gut, metabolism and brain
The stench of death hung over Lake Griffin in central Florida. Along its shores, the rotting carcasses of alligators were turning up in alarming numbers. Something was killing one of America’s apex predators, and nobody knew what it was.
The animals had begun behaving bizarrely. Some staggered along the shoreline as though drunk. Others appeared dead, except for occasional muscle twitches. People started calling them “zombie alligators.” Some struggled to keep their heads above water. Alligators drowned belly-up.
By the late 1990s, hundreds of alligators had died, and a team of scientists from 13 agencies was scrambling to find an explanation. There was no obvious injury—no attack wounds or gunshots. Was it pesticides or some other deadly toxin? A heavy metal in the water?
Exhaustive testing ruled out the main suspects. Autopsies were disappointing. The animals looked healthy, even under the microscope.
Blood testing of live affected animals ruled out infection, too. American alligator blood contains antibiotic proteins—it kills bugs like Salmonella and E. coli on contact—and these alligators’ immune systems were as potent as ever.
Then, years into the plague, at a conference, one of the alligator team met Dale Honeyfield from the United States Geological Survey. He was researching salmon that showed similar symptoms. He had discovered that the fish were suffering from a severe shortage of one of the most basic nutrients required for life: vitamin B1, or thiamine.
When the alligator team heard about this missing vitamin, it seemed unlikely. But it proved right. The trail led to the gators’ food supply.
Agricultural runoff had caused a bloom of algae, which had killed off a number of fish species. However, one fish, gizzard shad, flourished in the algae bloom. This fish contained thiaminase, an enzyme that destroys thiamine.
Because it had become the most plentiful food source, the Lake Griffin alligators were eating a lot of gizzard shad—far more than they normally would, and often with little else. Researchers suspected this vitamin-depleting diet was contributing to neurological damage so severe that the reptiles could no longer control their movements.1
The alligators weren’t starving. They were eating themselves into a deadly nutritional deficiency.
It seems bizarre, but the Florida alligator story is not without parallels. Veterinary medicine recognizes thiamine-related neurological disease across species.
In cattle and sheep, thiamine deficiency can cause cerebrocortical necrosis—death of brain tissue. Horses eating bracken fern containing thiaminase can develop thiamine deficiency, while foxes and cats fed thiaminase-containing raw fish are also at risk.
Veterinarians recognize these dietary hazards and use thiamine replacement to treat affected animals. Early intervention offers the best chance of recovery.
Meanwhile, thousands of miles away from Florida, another medical mystery was unfolding, this time involving human babies. In the autumn of 2003, doctors in Israel were confronted with several babies arriving at hospitals with vomiting, lethargy and strange neurological symptoms.
Some had developed abnormal eye movements. Others suffered seizures, stopped breathing or slipped into comas. Two infants died of heart failure.
The children had little in common. But as doctors compared their histories, one connection emerged: All had been fed the same popular soy-based infant formula, manufactured in Germany and marketed in Israel under the brand name Remedia. The label said the formula was fit for pediatric growth requirements, but when health authorities tested it, they discovered one essential vitamin was virtually absent: thiamine.
Remedia baby formula was quickly withdrawn from the market, and parents across Israel were urged to have their babies tested. One five-and-a-half-month-old boy, admitted with vomiting and abnormal eye movements, began improving within hours of receiving vitamin B1. Another baby, who had deteriorated into seizures and coma before doctors recognized the outbreak, improved with treatment but was left with neurological impairments.
When the doctors screened 156 other babies who had been drinking the formula, several had abnormal thiamine status although their parents had noticed little or nothing wrong. On closer examination, some showed signs of irritability, lethargy, poor growth or developmental delay—symptoms easily attributed to ordinary childhood illnesses.2
The tragedy exposed two glaring truths about vitamin B1 deficiency: It can be catastrophic, and initially, or with suboptimal levels over a long period, symptoms may be so vague that the underlying problem goes completely unrecognized.
Now some researchers are asking if the same diagnostic blind spot is much farther reaching. They’re wondering if an insidious thiamine deficiency affects people who are getting enough via diet, whose symptoms are blamed on other conditions and whose doctors rarely think to test for this deficiency.
Thiamine deficiency was once notorious for causing beriberi, a potentially fatal disease that swept populations relying on refined grains including rice, which were sheared of their basic nutrients when modern food processing was introduced. A collection of reports in the medical literature from the late 19th century describes severe cases.
One 26-year-old Scottish sailor returned from South America barely able to walk. Along with faintness and low-grade fever, he experienced constipation, loss of appetite and heart palpitations. Then came a gradual weakening of his legs, and soon of his forearms and hand grip.
He was carried home on board his ship to gradually recover at the Royal Infirmary at Edinburgh. Other patients swelled with fluid or struggled to breathe as their hearts failed.3
The breakthrough came when Christiaan Eijkman, a Dutch military physician, noticed that chickens fed white rice developed a paralyzing illness, but those fed brown rice did not. Diets dominated by polished white rice led to higher rates of beriberi in humans, Eijkman observed.
It wasn’t until 1926 that scientists isolated vitamin B1, or thiamine. Later, when wheat flour and other staples were enriched with synthetic vitamin B1, Eijkman received a Nobel Prize in medicine, and the banishment of beriberi in the developed world was considered a medical triumph.
It was a success portrayed as a problem solved. Deficiency became associated chiefly with severe malnutrition and heavy drinking, leaving doctors less likely to suspect it in everyone else.
Yet a growing body of evidence points to thiamine deficiency in unexpected places. It shows up in people with diabetes and metabolic syndrome, in some people using weight-loss drugs, and in people with gastrointestinal issues, unexplained anxiety and sleep disturbances.
Researchers are also investigating thiamine’s role in chronic fatigue, obesity, cardiovascular disease and neurological disorders, including Alzheimer’s and Parkinson’s diseases. Some studies suggest low vitamin B1 status is far more common in certain patient groups than doctors recognize (see below). Others suggest adequate thiamine consumption but impaired thiamine metabolism, which affects energy production in the body.
Among those raising the alarm are researcher and science writer Chandler Marrs and the late physician Derrick Lonsdale, who spent decades investigating thiamine deficiency. In a 2021 review paper, they argued that modern diets high in sugar and refined carbohydrates, medicines, and other chemical exposures with thiamine-disrupting mechanisms drain people of this essential nutrient.
“The assumption is that thiamine status is taken care of by food, and unless you’re alcoholic or severely malnourished, you have enough,” says Marrs. “But thiamine is the gatekeeper to energy metabolism, so if it’s low, nothing works well.”
Unlike the alligators of Lake Griffin, people don’t need to consume a vitamin-destroying enzyme to run short of B1. They don’t have to appear undernourished, either. They are more likely to appear overfed, sometimes obese, and they could be eating what the government considers adequate thiamine in their diet. Without proper testing and recognition of what Marrs and Lonsdale called “gradations of disease,” they can still be thiamine deficient—and malnourished.
Alcohol, certain medicines (see below) illness and high-carbohydrate diets can tip the balance between the thiamine the body receives and the amount it needs. “This pushes many people into a state of chronic deficiency, one that is simple to correct if identified early,” says Marrs. Yet it often goes unrecognized—and even those diagnosed, she warns, may spend decades “undertreated, and getting worse and worse.”
Exhausted, irritable, and struggling to think straight? Thiamine deficiency is unlikely to be the first suspect. Yet these can be its earliest warning signs, according to Marrs and Lonsdale. Mood swings, forgetfulness, poor sleep and a waning appetite all point to so many other problems, but they are also early signs of not enough thiamine to fuel the body.
Digestive discomfort and problems moving food through the digestive tract may be early clues, too, followed by food intolerances and vomiting as the deficiency worsens. And digestive symptoms may mean there’s a deficiency in the gut even if systemic levels are adequate.4
Emergency physician Dr So Sakamoto of Japan’s Asahi General Hospital gives a similar warning in a 2026 Cureus editorial. Nausea, vomiting, loss of appetite and abdominal discomfort can signal gastrointestinal beriberi yet may be dismissed as a passing stomach illness.
“Failure to recognize these early stages may allow progression to irreversible neurological or cardiac injury,” he writes. Because laboratory results can take days, he urges emergency doctors to “suspect and treat” when a patient’s history and symptoms point to deficiency rather than waiting for confirmation.5
But recognizing a shortage is not as simple as ordering a blood test. What counts as “enough” thiamine? It turns out we don’t know. Marrs points to the lack of medical consensus on what constitutes deficiency and challenges the recommended daily allowance (RDA) set for thiamine 80 years ago based on tiny studies, including an influential experiment involving just seven men.
How could that foundation adequately reflect modern diets heavy in refined carbohydrates and sugar, let alone the effects of illness and modern medicines? Meeting the RDA is not the same as getting enough, and blood tests don’t always reveal what is happening inside tissues.
That distinction is especially important in people who don’t appear to be underfed. Obesity can conceal nutritional shortfalls, while diabetes may alter how the body handles thiamine.
In 2007 Professor Paul Thornalley and colleagues at the University of Essex compared 74 people with diabetes to 20 healthy volunteers. Plasma thiamine concentrations were around 75 percent lower in those with either type 1 or type 2 diabetes.
Their kidneys were clearing the vitamin from the blood at dramatically higher rates—24 times higher in type 1 and 16 times higher in type 2. The problem wasn’t necessarily too little thiamine coming in but too much being lost.
What’s more, changes in the patients’ red blood cells helped mask the shortfall on conventional blood thiamine tests. The findings did not establish that B1 deficiency causes diabetes, but they challenged the assumption that an adequate diet guarantees an adequate supply.6
Could a shortfall in B1 explain some of diabetes’s damaging complications? Thornalley went on to explore thiamine’s potential to protect the kidneys, and this work is ongoing.7
Meanwhile, a 2020 study of 80 people with type 2 diabetes and 20 healthy volunteers found lower blood levels of thiamine’s active form in patients with diabetic retinopathy—the eye disease that can threaten sight. Levels of B1 tended to fall as the disease became more advanced, raising the possibility that inadequate thiamine contributes to eye damage commonly attributed to diabetes.8
Obesity can conceal nutritional shortfalls, too. A 2025 study found thiamine levels below the normal reference range in almost one-third of 146 US veterans attending a weight management clinic. None had undergone weight-loss surgery, and the researchers excluded people with recent alcohol abuse. They concluded that obese patients should have nutritional screening.9
There are hints of a connection with fatty liver disease too: A small Ukrainian study published in 2025 found lower blood levels of B vitamins, including thiamine, in patients with both metabolic fatty liver and acid reflux. However, it couldn’t say whether the vitamin shortage contributed to liver disease or resulted from it.10
Some animal studies suggest thiamine can influence how the body handles excess fuel. In 2010, Japanese researcher Takao Tanaka and colleagues found that B1 supplementation curbed weight gain and reduced fat accumulation in the liver, heart and skeletal muscles of rats prone to obesity and diabetes.11
And a 2021 experiment in sheep produced another striking result: Animals given high-dose B1 maintained normal liver-fat levels despite eating the same high-calorie, carbohydrate-heavy diet that caused fatty liver in untreated animals. Their elevated blood glucose also fell, although insulin sensitivity did not improve.12
Together, these studies raise questions about the role of vitamin B1 in the current epidemics of human obesity and fatty liver disease.
But eating enough thiamine is only part of the story. The digestive system has to absorb the vitamin. Sugar supplies calories without B1, while refining grains strips away much of their natural vitamin content, although enrichment replaces some. It’s a process that can be thrown off by illness or surgery, too.
Research into thiamine deficiency after gastric bypass has pointed to one complication: bacterial overgrowth in the gut. In a 2008 study, researchers in Washington, DC, identified 21 gastric bypass patients with low thiamine levels and breath-test results consistent with small intestinal bacterial overgrowth (SIBO).
Even when they were given thiamine supplements, these patients remained thiamine deficient. Nine subsequently received antibiotics; all nine had normal thiamine levels when retested. The findings suggested that bacterial overgrowth could help explain why replacing the vitamin was not enough, and antibiotic treatment of the overgrowth seemed to deal with the underlying problem so thiamine could go on board.13
For Jo Dixon, a hospital consultant and mother of four in Norwich in the UK, an overlooked gut problem became central to her search for answers. In her memoir, The Missing Link in Dementia (Wrate’s Publishing, 2020), she recounts how, in her early 40s, she began falling over, forgetting things and getting lost while driving familiar routes. She feared early-onset dementia, but her bizarre collection of symptoms included nerve pain, mobility problems and digestive symptoms.
Discovering she had beriberi brought hope, but intravenous thiamine provided only temporary relief: Within 48 hours, Dixon’s symptoms would begin returning, and oral thiamine didn’t help. She eventually discovered a congenital malrotation of the bowel, a condition in which the intestines twist and potentially cut off blood supply.
It was fixed with surgery, but Dixon believed that years of intestinal stasis had encouraged bacterial overgrowth and undermined her thiamine supply. “The more I searched for data to support my belief that thiamine was destroyed by gut bacteria, the more confirmation I found in articles and papers that featured mainly in specialized journals or in those written decades ago,” she wrote.
She suspected that some of those bacteria were destroying the vitamin by producing thiaminases—enzymes of the same class implicated in the Lake Griffin alligators. Certain bacteria, including the superbug Staphylococcus aureus and some types of Bacillus and Clostridium, do produce thiamine-destroying enzymes, making this a plausible mechanism.14
There may also be ways to protect the vitamin from destruction. In 2023, researchers published laboratory experiments showing that vitamin C strongly inhibited the breakdown of thiamine by a bacterial thiaminase I enzyme. The effect was reversible, and whether vitamin C could offer similar protection in the human gut—or help people with SIBO—remains untested.15
Dixon describes how she recovered after cyclic antibiotic treatment for SIBO alongside 500 mg per day of benfotiamine, a lab-created thiamine derivative (see below). In her experience, she needed to address her gut problem to address B1 depletion.
Dixon’s fear that she was developing dementia points to the frightening effects a thiamine shortage can have on the brain.
Wernicke’s encephalopathy. Medicine recognizes a potentially fatal form of this damage: Wernicke’s encephalopathy, commonly associated with alcohol misuse. Yet the diagnosis is frequently missed.
A Western Australian study looking at brains on autopsy identified 131 cases of Wernicke’s encephalopathy, most associated with alcoholism, but only one in five had been diagnosed during life; 80 percent had gone unrecognized.16
And Wernicke’s is not confined to heavy drinkers. A Norwegian study published in 1989 examined almost 7,000 autopsies over five years and found 52 cases, including 12 in people without alcoholism. At least seven of those nonalcoholic patients had active disease, yet none had been diagnosed during life or given thiamine treatment.17
Confusion and reduced alertness were the main clues; the eye abnormalities doctors associate with the condition were uncommon. Even among patients with alcoholism who received thiamine, treatment often came too late.
More than three decades ago, the authors urged doctors to consider Wernicke’s in anyone with prolonged malnutrition. They warned that confusion or impaired consciousness might be its most obvious symptoms.
“Even the slightest suspicion of Wernicke’s encephalopathy should prompt immediate administration of large doses of thiamine parenterally,” that is, by injection or infusion, they said. Yet in 2026, Sakamoto writes that thiamine deficiency is still mostly unrecognized and urges emergency doctors to “suspect and treat.”
Alzheimer’s disease. Brain damage caused by severe thiamine deficiency raises a bigger question: Could problems with thiamine-dependent energy production also contribute to the slower decline seen in neurodegenerative disease? Wernicke’s is different from Alzheimer’s or Parkinson’s, but researchers are looking at how B1 could help.
It’s thiamine availability inside the brain that deserves more attention than the thiamine we eat, thinks Gary Gibson, professor of neuroscience at Weill Cornell Medicine and a laboratory director at New York’s Burke Neurological Institute. “While I’m convinced that low brain thiamine is a concern in Alzheimer’s disease, we don’t think this is necessarily because of dietary intake of thiamine,” he says.
His team is investigating benfotiamine, a thiamine derivative that can raise blood B1 to levels ordinary thiamine cannot achieve. An encouraging pilot trial showed slower progression of cognitive impairment in the benfotiamine group compared to controls.
Alongside laboratory research, that trial has led to US National Institutes of Health funding of a larger trial comparing daily benfotiamine doses of 600 mg and 1,200 mg to placebo at 46 US sites. Enrollment is now complete, Gibson reports, and treatment is scheduled to finish at the end of 2027. The study will test whether this pharmacological boost of thiamine can slow Alzheimer’s progression.
Parkinson’s disease. Memory is not the only brain function researchers have tried to support with thiamine. In Italy, the late physician Antonio Costantini and colleagues investigated high-dose B1 in people with Parkinson’s disease.
In a 2015 study of 50 people with Parkinson’s, they reported that average symptom scores fell by half within three months of twice-weekly high-dose thiamine injections (100 mg each) alongside unchanged drug treatment. Motor exam scores improved by about 55 percent.
On their website (highdosethiamine.org/videos) and their YouTube channel (Antonio Constantini, @antoniocostantini2597), Costantini’s team has also documented dramatic videos of patients before and after receiving thiamine treatment. One video shows a woman, “Patient 4,” who appears to be in her 30s, can’t walk a straight line and is trembling uncontrollably.
After just one infusion of vitamin B1, she appears remarkably improved. “It’s wonderful!” she says, grinning. Three months on, another video shows her walking toward the camera with a smile and no apparent symptoms.
In another interview recorded in 2018, a man named Marco describes being diagnosed with Parkinson’s eight years earlier. Earlier footage shows a pronounced hand tremor. Two years after beginning thiamine therapy, he reports having stopped his Parkinson’s medication and says his rehabilitation specialist considers him “asymptomatic.”
From blood sugar and digestion to memory and movement, these investigations return to the same essential task: turning food into usable energy. Thiamine is not a miracle cure for all ailments, but it does show promise. And it makes it clear that thiamine’s medical story was far from finished when beriberi’s cause was discovered.
The challenge is to recognize thiamine-related problems. Marrs and Lonsdale argue for considering deficiency when fatigue, brain fog, digestive trouble and other unexplained symptoms may be the only clues.
That goes beyond the urgent “suspect and treat” advice for Wernicke’s encephalopathy and potentially lethal brain damage. It also means asking why a shortage developed, whether through diet, medicines, gut dysbiosis or other causes.
The Lake Griffin alligators offered a dramatic lesson in what happens when thiamine goes missing. In humans, as the babies in Israel revealed, the warning signs may be more subtle. A century after scientists isolated vitamin B1, there’s still reason to ask whether medicine is overlooking what happens when the body can’t get enough of it.
A 2026 pharmacovigilance study by Chinese researchers found a safety signal for thiamine deficiency with 38 drugs.1 Here are a few of the top drugs known to interfere with thiamine absorption or to reduce appetite so people eat too little to maintain adequate B1 levels.
Metformin. Laboratory studies show this widely prescribed diabetes medicine can inhibit a transporter involved in thiamine absorption.2
GLP-1 receptor agonist drugs. As millions turn to drugs like Ozempic, Wegovy, Zepbound and Mounjaro to shed unwanted pounds, cases of Wernicke’s encephalopathy—a potentially life-threatening brain disorder caused by thiamine deficiency—have been reported with the drugs’ main ingredients, semaglutide and tirzepatide.3
GLP-1 drugs don’t appear to destroy vitamin B1 directly. Rather, their powerful appetite-suppressing effects, sometimes accompanied by bouts of nausea and vomiting, can leave patients eating too little and severely deficient in thiamine.4
One case report describes a 37-year-old man who developed slurred speech, headaches, trouble finding words and restricted eye movements after taking semaglutide. He was diagnosed with nonalcoholic Wernicke’s encephalopathy and began to recover after receiving 500 mg of thiamine by IV three times a day.5
Cancer treatments. Fluorouracil (5-FU), a chemotherapy agent used widely to treat various tumors, has been associated with potentially fatal Wernicke’s in case reports and may interfere with thiamine metabolism.6 Poor appetite and treatment-related vomiting can compound the risk.
Fedratinib, used to treat myelofibrosis, carries a warning: Its US prescribing information requires thiamine assessment before treatment and 100 mg of oral thiamine daily during treatment, with further monitoring as indicated.7
Diuretics. Diuretics such as furosemide, torasemide and hydrochlorothiazide, commonly prescribed to treat fluid retention, can increase urinary thiamine losses and have been linked to lower thiamine levels. Long-term use has been associated with deficiency in patients with heart failure.1
A 2016 case report by doctors at University Hospital Kerry in Ireland describes a 34-year-old man who came to the emergency department in alcohol withdrawal. Despite high-dose thiamine therapy given intravenously, his decline continued.
He became increasingly weak and uncoordinated as well as more confused. He also developed rapid uncontrollable eye movements, one of the classic signs of Wernicke’s encephalopathy.
Doctors noted that his magnesium levels were below the normal range as well. When they added magnesium—a cofactor needed to convert thiamine into its active form, thiamine diphosphate (TDP, also called TPP)—he made a full recovery.1
When taking thiamine, it’s best to take it with a full multivitamin including the complex of B vitamins, which are also necessary to the function of the same metabolic machinery.
Today’s thiamine recommendations have a surprisingly thin foundation. Vitamin B1 appeared in the first American Recommended Dietary Allowances in 1941, with amounts linked to calorie intake. A 1979 experiment involving just seven healthy young men became an influential building block of modern recommendations.
Researchers restricted and restored their thiamine, measuring urinary losses and a thiamine-dependent enzyme to estimate requirements.2 They’ve never been revised since, and today’s adult RDAs remain 1.1 mg for women and 1.2 mg for men. Most multivitamins contain about 1.5 mg.
The UK’s National Health Service recommends 25–100 mg daily for mild adult deficiency, with higher doses prescribed for more severe cases. Clinical researchers are exploring much larger doses and forms for specific conditions.
Thiamine hydrochloride and mononitrate are the standard water-soluble forms in supplements. In a randomized trial involving 40 people with inactive inflammatory bowel disease and persistent fatigue, oral thiamine at 600–1,800 mg daily for four weeks significantly reduced fatigue compared with placebo. Treatment was well tolerated, with only mild side effects reported.3
Benfotiamine is a synthetic derivative of thiamine that converts into thiamine in the body and is being investigated as a treatment for Alzheimer’s disease. A 70-person pilot trial used 300 mg twice daily for one year and reported no treatment-related adverse events. Participants showed significantly less worsening on a clinical measure of dementia.4 The larger BenfoTeam trial currently underway includes 600 mg and 1,200 mg daily doses.5
TTFD, or fursultiamine, is another well-absorbed synthetic derivative. Human absorption studies have examined 100 mg doses, but an effective treatment dose has not been established.6
Most vitamin B1 tests measure the vitamin’s concentration in blood, which gives a snapshot of circulating thiamine and can be influenced by recent food or supplement intake.
A less accessible alternative, the erythrocyte transketolase activation coefficient (ETKAC) test, examines thiamine’s function based on the activity of a thiamine-dependent enzyme in red blood cells before and after adding the vitamin’s active form.
Rosalind Franklin University’s Clinical Immunology Laboratory in North Chicago, Illinois (rosalindfranklin.edu), currently provides this functional test. It requires a refrigerated blood sample, preferably arriving within 48 hours, and gives a turnaround time of five to seven business days.
Patients outside the US should ask their clinician or laboratory to confirm costs, referral requirements and international shipping arrangements before collecting a sample.
In Britain, University Hospitals Birmingham (uhbpathology.com) also lists red cell transketolase as a referral test. Availability must be confirmed in advance. Ask specifically for “transketolase activity with thiamine stimulation and an activation coefficient”; a test labeled “vitamin B1” may measure blood levels instead.
What do you think? Start a conversation over on the... WDDTY Community
Great news! Discounts are available based on your cart total. Check the details below: